Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Comparer
Comparer des captures archivées
Cette vue met en évidence des différences de texte entre deux captures archivées. Elle n’interprète pas le sens et ne fournit pas de directives.
Changements descriptifs seulement
Cette comparaison met en évidence des changements de texte entre des captures archivées. Elle n’interprète pas le changement et ne fournit pas d’avis médical. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Besoin de citer cette comparaison? Voir /cite.
Capture précédente
What's new: Natural and non-prescription health products - Canada.ca
18 avr. 2025
legacy-hc-2025-04-21
ID 176862
Capture suivante
What's new: Natural and non-prescription health products - Canada.ca
2 janv. 2026
hc-20260101
ID 429041
updated5 sections changed
5 sections modifiées0 ajoutées0 retirées+79 / -35 lignesVariation: 9%
--- +++ @@ -29,6 +29,82 @@ Interim guide on the production of ethanol for use in alcohol-based hand sanitizers Guide on Health Canada's Interim Expedited Licensing Approach for the Production and Distribution of Alcohol-Based Hand Sanitizers 2025+December+Notice: Multiple additions to the Prescription Drug List (PDL)+[2025-12-18]+Appendix 1: Established acceptable intake (AI) limits for N-nitrosamine impurities+[2025-12-17]+November+Updated: Guidance document - Preparation of regulatory activities in non-eCTD format+[2025-11-27]+Updated: Filing submissions electronically+[2025-11-05]+October+Notice: Multiple additions to the Prescription Drug List (PDL)+[2025-10-30]+Implementation of International Council for Harmonisation (ICH) Q12 - Technical and regulatory considerations for pharmaceutical product lifecycle management: Notice+[2025-10-17]+Health Canada implementation of the ICH E6(R3) guideline: Notice to stakeholders+[2025-10-17]+Release of draft (step 2) ICH Guideline Q3E: Impurities: Guideline for extractables and leachables+[2025-10-17]+September+Consultation: Adding melatonin for sleep-related use in the pediatric population to the Prescription Drug List+[2025-09-16]+Third party authorization form+[2025-09-10]+Notice of amendment: Addition of melatonin to the Prescription Drug List+[2025-09-09]+Health Canada and the Public Health Agency of Canada’s report on red tape reduction+[2025-09-08]+Good manufacturing practices guide for natural health products (GUI-0158)+[2025-09-04]+August+Notice: Multiple additions to the Prescription Drug List (PDL)+[2025-08-28]+Notice to stakeholders: Publication of Non-prescription Drug Cough, Cold and Flu Labelling Standard+[2025-08-19]+Appendix 1: Established acceptable intake (AI) limits for N-nitrosamine impurities+[2025-08-01]+Updated: Guidance on nitrosamine impurities in medications+[2025-08-01]+July+Notice of amendment: Nicotine tablets exempted from the Prescription Drug List+[2025-07-21]+Notice of intent: Revisions to the Prescription Drug List for nicotine buccal pouches+[2025-07-14]+Notice of intent: Exempting nicotine tablets from the Prescription Drug List+[2025-07-14]+Notice: Revisions to the Drug Product Database's terminology page+[2025-07-04]+June+Notice to stakeholders – Implementation of ICH M13A: Bioequivalence for immediate release solid oral dosage forms+[2025-06-27]+Q13: Continuous manufacturing of drug substances and drug products+[2025-06-27]+Q5A(R2): Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin+[2025-06-27]+Q3C(R9): Impurities: Residual solvents+[2025-06-27]+Release of draft (step 2) ICH guideline Q1: Stability testing of drug substances and drug products+[2025-06-27]+Release of draft (Step 2) ICH guideline M13B: Bioequivalence for immediate-release solid oral dosage forms+[2025-06-27]+Release of draft (Step 2) ICH guideline M4Q(R2): Common Technical Document (CTD)-Quality+[2025-06-27]+Release of draft (Step 2) ICH guideline E20: Adaptive clinical trials+[2025-06-27]+Release of draft (Step 2) ICH guideline E21: Inclusion of pregnant and breastfeeding individuals in clinical trials+[2025-06-27]+Release of draft (Step 2) ICH M11: Clinical electronic Structured Harmonised Protocol (CeSHarP) – Technical specification+[2025-06-27]+Notice: Multiple additions to the Prescription Drug List (PDL)+[2025-06-24]+April+Notice: Multiple additions to the Prescription Drug List (PDL)+[2025-04-29]+Updated: Filing submissions electronically+[2025-04-25] March Nitrosamine impurities in medications: Recalls [2025-03-31]@@ -60,8 +136,6 @@ January Updated: Filing submissions electronically [2025-01-27]-Notice to Stakeholders – Consultation on the Impacts of Implementation of ICH M13A: Bioequivalence for Immediate Release Solid Oral Dosage Forms-[2025-01-17] Notice – Implementation of International Council for Harmonisation (ICH) S1B(R1): Testing for Carcinogenicity of Pharmaceuticals [2025-01-17] 2024@@ -90,10 +164,10 @@ September How to develop a corrective and preventive action plan (CAPA) [2024-09-27]-Authorization for a third party to file a regulatory activity on behalf of the manufacturer/sponsor+Authorization for a third party to file a regulatory activity on behalf of the manufacturer/sponsor (PDF format) [2024-09-11] August-Notice - Release of the final guidance document: “Switching from prescription to non-prescription status”+Notice - Release of the final guidance document: "Switching from prescription to non-prescription status" [2024-08-14] July Appendix 1: Established acceptable intake (AI) limits for N-nitrosamine impurities@@ -359,11 +433,6 @@ Updates to the Prescription Drug List [2017-02-10] 2016-December-Natural and Non-prescription Health Products Directorate (NNHPD)-six-month-calendar of activities: January to June 2017-[2016-12-29] November Updates to the Prescription Drug List [2016-11-16]@@ -377,8 +446,6 @@ [2016-08-26] Prescription Drug List [2016-08-18]-Natural and Non-prescription Health Products Directorate (NNHPD) six-month calendar of activities: July to December 2016-[2016-08-17] Prescription Drug List [2016-08-09] May@@ -391,18 +458,10 @@ [2016-04-22] The Non-Prescription and Natural Health Products Directorate is moving - new physical and mailing addresses [2016-04-14]-Summary Report on the Consultation on a Framework for Consumer Health Products: What We Heard-[2016-04-01] March Updated - Prescription Drug List [2016-03-22] February-Natural and Non-prescription Health Products Directorate (NNHPD)'s Calendar of Activities (January to June 2016)-[2016-02-10]-Consultation - New Monographs (First Aid Antiseptics)-[2016-02-09]-Consultation - Revised Monograph (Selenium)-[2016-02-09] Final Mongraph for Antiseptic Skin Cleanser [2016-02-09] Consultation - Revised Monograph (Multi-Vitamin/Mineral Supplements)@@ -420,8 +479,6 @@ [2016-01-08] 2015 December-Consultation - New Monograph (Medicated Vapours)-[2015-12-08] Final Monograph for Hydrocortisone [2015-12-08] Final Monograph for Maitake@@ -469,8 +526,6 @@ [2015-07-28] Finalized New Labelling Standard (Oral Stool Softener Laxatives) [2015-07-28]-NNHPD's Calendar of Activities (July to December 2015)-[2015-07-16] Revised Monograph (American ginseng) [2015-07-08] June@@ -479,8 +534,6 @@ Revised Monograph (Hard Surface Disinfectants) Revised Monograph (Traditional Chinese Medicine Ingredients) Revised Monograph (Homeopathy)-Consultation - New Labelling Standard (Oral Adult Decongestant)-[2015-06-01] May Prescription Drug List [2015-05-29]@@ -515,8 +568,6 @@ Prescription Drug List [2014-12-05] November-Consultation - Consumer Health Products Framework-[2014-11-27] Consultation - Development of new monograph (Chlorella) [2014-11-18] Consultation - Development of new monographs (Betaine/Betaine Hydrochloride and Olive Leaf - Olea Europaea)@@ -527,8 +578,6 @@ Consultation -Development of new monographs (Bearberry - Arctostaphylos uva-ursi and Aromatherapy - Essential Oils) [2014-10-07] September-Natural and Non-prescription Health Products (NNHPD) six-month calendar of activities: July to December 2014-[2014-09-25] Prescription Drug List [2014-09-16] August@@ -536,8 +585,6 @@ [2014-08-26] Prescription Drug List [2014-08-22]-Natural and Non-prescription Health Products Directorate - Quarterly snapshot - Quarter 1 (Fiscal year 2014-2015)-[2014-08-05] July Non-prescription drug monograph attestation pilot [2014-07-10]@@ -584,8 +631,6 @@ [2014-01-28] Consultation - A Revised Approach to NHP Site Licensing [2014-01-23]-Natural Health Products Directorate (NHPD) six-month calendar of activities: January to June 2014-[2010-01-15] Updated - Natural health products online system standard terminology guide [2014-01-10] Natural Health Product Licence Application Form User Manual@@ -593,5 +638,4 @@ Guidance document on how to interact with the Natural Health Products Directorate electronically [2014-01-06] Page details-Date modified:-2025-03-31+2025-12-18